As of 9:32am ET
| +0.01 / +0.11%|
The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 11.07, with a high estimate of 16.00 and a low estimate of 5.00. The median estimate represents a +21.40% increase from the last price of 9.12.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.